Skip to main content
GENOLUTION INC. logo

GENOLUTION INC. — Investor Relations & Filings

Ticker · 225220 ISIN · KR7225220003 KO Manufacturing
Open in API
Filings indexed 294 across all filing types
Latest filing 2026-04-08 Director's Dealing
Country KR South Korea
Listing KO 225220

About GENOLUTION INC.

https://genolution.co.kr/

Genolution Inc. is a biotechnology company specializing in molecular diagnostics (MDx) and RNA interference (RNAi). The company develops and manufactures In-Vitro Diagnostic (IVD) solutions, including automated nucleic acid extraction systems, reagents, and consumables for genetic testing and life sciences research. Its core offerings support a wide range of applications from clinical diagnostics to genomics. In parallel, Genolution provides RNAi-related products and services, such as double-stranded RNA (dsRNA) synthesis for gene expression studies and agricultural development. The company focuses on creating faster and more affordable solutions for both the diagnostics and research markets.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a Korean Director and Major Shareholder Ownership Report (Form 6.1) detailing changes in share ownership by an executive (임원), including acquisition dates, share counts before and after, and trading details. This is not a corporate share buyback but personal insider transactions. It matches the ‘Director’s Dealing’ category (Code: DIRS).
2026-04-08 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a Korean regulatory filing titled “사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고,” which translates to “Notification regarding the appointment, dismissal or mid-term resignation of outside directors.” It details changes in the company’s board composition (outside director appointment), including names, dates, and terms. This clearly falls under announcements of changes in the board of directors or senior management. Therefore, it is classified as Board/Management Information (MANG).
2026-03-30 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회결과” (Regular Shareholders’ Meeting Results) and provides detailed vote outcomes for each agenda item, including percentages of approval and election results of directors. This aligns precisely with a Declaration of Voting Results at a general meeting. It is not an AGM presentation or a full report but the official voting results announcement.
2026-03-27 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for the company 'Genolution' (주식회사 제놀루션). It includes the independent auditor's report, financial statements (Statement of Financial Position, Comprehensive Income Statement, Statement of Changes in Equity, Statement of Cash Flows), and detailed notes (주석). It covers the fiscal period from January 1, 2025, to December 31, 2025. Since it is a standalone audit report containing financial statements and auditor's opinion, it is classified as an Audit Report (AR). FY 2025
2026-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by Genolution. It contains the auditor's opinion (unqualified/appropriate), financial statements (consolidated and separate), and key financial metrics for the fiscal year ending 2025-12-31. While it provides financial data, it is specifically the regulatory filing of the audit report itself, which falls under the 'Audit Report / Information' category. FY 2025
2026-03-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details the acquisition of shares by an executive (Kim Min-iee) of Genolution. This type of filing, which reports personal share transactions by company directors and executives, is classified as 'Director's Dealing' (DIRS).
2026-03-18 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.